semaglutide for cutting bodybuilding Ozempic bodybuilders push open access to weight loss drug Semaglutide Plus | Genesis Health

As of early 2026, several potent single, dual, and triple incretin receptor agonists are in Phase 2/3 trials for MASH including : Survodutide : A dual glucagon (GCGR)/GLP-1 receptor agonist that has shown significant MASH resolution in Phase 2 trials

A retrospective analysis shows a significant reduction in BMI with GLP-1s but no meaningful benefit in disability or disease progression in multiple sclerosis.

PlexusDx provides detailed guidance to help you inject safely and confidently at home

Discover science-backed methods to lock in weight loss, maintain metabolic changes, and avoid common pitfalls after GLP-1 therapy ends

GLP-1 medications like Ozempic and Mounjaro may support fertility by aiding weight loss, reducing inflammation, and improving hormone balance, but theyre not a cure for infertility